West Pharmaceutical ServicesNYSE: WST

West Pharmaceutical Services, Inc. (NYSE: WST), a leading company in injectable drug solutions, has announced its participation in several upcoming conferences. They will present at the UBS Global Healthcare Conference in California on November 12, 2024, the Jefferies Healthcare Conference in London on November 19, 2024, and the Stephens Annual Investment Conference in Nashville on November 21, 2024. A live audio webcast of these presentations will be accessible on the company's website, with replays available for about 90 days after the events.

West Pharmaceutical Services, Inc. (NYSE:WST) held its Q3 2024 earnings conference call on October 24, 2024, at 9:00 AM ET. The call featured company representatives, including John Sweeney, Eric Green, and Bernard Birkett, along with participants from various financial firms. The operator welcomed everyone and thanked them for joining the call.

On Thursday, West Pharmaceutical Services, Inc. (WST) announced an adjusted earnings per share (EPS) of $1.85, which is lower than the $2.16 reported last year, but it exceeded the expected consensus of $1.50.

West Pharmaceutical Services (WST) reported quarterly earnings of $1.85 per share, which is higher than the Zacks Consensus Estimate of $1.51 per share. However, this is lower than the earnings of $2.16 per share from the same period last year.

On Thursday, West Pharmaceutical Services increased its yearly profit prediction after surpassing Wall Street's expectations for quarterly revenue and profit. The company is counting on the growing need for cartridges and syringes that are used to produce injectable treatments.

A conference call is set for 9 a.m. EDT today in Exton, Pennsylvania.

WST's results for the third quarter show improvement in the Proprietary Products area after a period of high customer destocking that negatively impacted sales in the second quarter.

EXTON, Pa., Oct. 22, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading company in innovative solutions for injectable drug delivery, has announced its participation in the 2024 PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Phoenix, AZ. The event will highlight the company's expertise in addressing industry challenges and trends in packaging and containment. "As biologic drugs become more common, injectables are now the fastest growing segment, presenting new challenges with complex molecules and treatment needs," stated Atul Patel, Vice President of Delivery Devices at West.

EXTON, Pa., Oct. 10, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a worldwide leader in creative solutions for injectable drug delivery, has announced that it will share its third-quarter financial results before the market opens on Thursday, October 24, 2024. Following this, there will be a conference call at 9:00 a.m. Eastern Time to discuss the results and future business outlook.